Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Marram generated +4.0% in 2025, taking advantage of a market disconnect to concentrate capital into high-conviction payment technology stocks while holding a high cash buffer (35% NAV) and locking in regional bank gains.
Full Quick Take
Marram generated +4.0% in 2025, taking advantage of a market disconnect to concentrate capital into high-conviction payment technology stocks while holding a high cash buffer (35% NAV) and locking in regional bank gains.
Marram posted a steady +0.7% net return for Q3 (+3.0% YTD), actively trimming regional banks on expanding valuations to fund fresh allocations in out-of-favor payments and biopharma while maintaining a large 31% cash cushion.
Full Quick Take
Marram posted a steady +0.7% net return for Q3 (+3.0% YTD), actively trimming regional banks on expanding valuations to fund fresh allocations in out-of-favor payments and biopharma while maintaining a large 31% cash cushion.
Marram returned +2.3% in Q2 2025 (+2.4% YTD), maintaining a resilient portfolio with 32% cash amidst widespread market exuberance, while selectively adding minor positions in FCNCA and PINS.
Full Quick Take
Marram returned +2.3% in Q2 2025 (+2.4% YTD), maintaining a resilient portfolio with 32% cash amidst widespread market exuberance, while selectively adding minor positions in FCNCA and PINS.
